- Home
- PRCH vs ZURA Comparison
PRCH vs ZURA Comparison
Compare PRCH & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRCH
- ZURA
- Stock Information
- Founded
- PRCH 2012
- ZURA 2022
- Country
- PRCH United States
- ZURA United States
- Employees
- PRCH N/A
- ZURA N/A
- Industry
- PRCH Computer Software: Prepackaged Software
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRCH Technology
- ZURA Health Care
- Exchange
- PRCH Nasdaq
- ZURA Nasdaq
- Market Cap
- PRCH 656.3M
- ZURA 69.9M
- IPO Year
- PRCH N/A
- ZURA N/A
- Fundamental
- Price
- PRCH $12.20
- ZURA $1.05
- Analyst Decision
- PRCH Strong Buy
- ZURA Buy
- Analyst Count
- PRCH 8
- ZURA 7
- Target Price
- PRCH $9.66
- ZURA $14.33
- AVG Volume (30 Days)
- PRCH 2.2M
- ZURA 759.8K
- Earning Date
- PRCH 08-05-2025
- ZURA 08-08-2025
- Dividend Yield
- PRCH N/A
- ZURA N/A
- EPS Growth
- PRCH N/A
- ZURA N/A
- EPS
- PRCH N/A
- ZURA N/A
- Revenue
- PRCH $427,150,000.00
- ZURA N/A
- Revenue This Year
- PRCH $4.28
- ZURA N/A
- Revenue Next Year
- PRCH $12.88
- ZURA N/A
- P/E Ratio
- PRCH N/A
- ZURA N/A
- Revenue Growth
- PRCH N/A
- ZURA N/A
- 52 Week Low
- PRCH $1.05
- ZURA $0.97
- 52 Week High
- PRCH $12.83
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- PRCH 67.10
- ZURA 41.68
- Support Level
- PRCH $10.55
- ZURA $1.03
- Resistance Level
- PRCH $12.09
- ZURA $1.22
- Average True Range (ATR)
- PRCH 0.71
- ZURA 0.09
- MACD
- PRCH 0.04
- ZURA -0.01
- Stochastic Oscillator
- PRCH 84.77
- ZURA 19.70
About PRCH Porch Group Inc.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.